STI/STD testing

STI PCR testing in Chiang Mai: 14- and 28-target panels

A practical guide to panel contents, genital and extragenital specimens, what the results can—and cannot—tell you, and how a doctor selects the appropriate test.

Quick answer

What is an STI PCR panel?

A multiplex PCR panel looks for genetic material from several organisms in one specimen. Klaibaan Clinic can arrange a 14-target panel, individual 7-target modules from the 28-target system, or the full 28-target option. The largest panel is not automatically the best choice: the doctor should match the panel and specimen to symptoms, exposure site, timing, and other tests you may need.

Who may benefit

When molecular testing may be considered

  • Discharge, burning urination, genital discomfort, sores, pelvic symptoms, or rectal symptoms
  • Possible genital, oral, or anal exposure to an STI
  • A partner diagnosed with an infection
  • Persistent or recurrent symptoms when a focused molecular panel may clarify the cause
  • Testing requested after clinical assessment even when symptoms are absent
Urgent symptoms: Severe pelvic or testicular pain, high fever, rapidly worsening genital ulcers, heavy bleeding, severe abdominal pain, or significant rectal bleeding may need urgent hospital assessment rather than waiting for panel results.
14-target panelA mixed panel covering common bacterial, viral, parasitic and fungal targets, including Group B Streptococcus.
Essential STI panel7 targets focused on common urogenital organisms.
Genital Ulcer panel7 viral and bacterial targets associated with genital ulcers.
Candidiasis panel7 Candida species.
Bacterial Vaginosis panel7 BV-associated or vaginal-microbiome targets.
Full 28-target optionCombines all four 7-target modules. It does not include Group B Streptococcus from the 14-target panel.
14 targets

What is included in the 14-target panel?

This panel includes ten bacterial targets, two viral targets, one parasite, and one fungal target.

  • Chlamydia trachomatis
  • Gardnerella vaginalis
  • Mycoplasma genitalium
  • Mycoplasma hominis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Ureaplasma urealyticum
  • Ureaplasma parvum
  • Group B Streptococcus
  • Haemophilus ducreyi
  • Herpes simplex virus 1
  • Herpes simplex virus 2
  • Trichomonas vaginalis
  • Candida albicans
Important: Organisms such as Gardnerella, Ureaplasma, Mycoplasma hominis, Group B Streptococcus, or Candida may be detected without proving that they caused the symptoms or require treatment. Clinical interpretation matters.

Essential STI

  • C. trachomatis
  • N. gonorrhoeae
  • M. genitalium
  • M. hominis
  • T. vaginalis
  • U. urealyticum
  • U. parvum

Genital Ulcer

  • HSV-1
  • HSV-2
  • Cytomegalovirus
  • Varicella-zoster virus
  • C. trachomatis serovar L target
  • T. pallidum
  • H. ducreyi

Candidiasis

  • C. albicans
  • C. glabrata
  • C. tropicalis
  • C. parapsilosis
  • C. krusei
  • C. lusitaniae
  • C. dubliniensis

Bacterial Vaginosis

  • Gardnerella vaginalis
  • Atopobium vaginae
  • Megasphaera type 1
  • BV-associated bacteria 2
  • Mobiluncus spp.
  • Bacteroides fragilis
  • Lactobacillus spp.
LGV wording: The Genital Ulcer module lists an LGV-associated C. trachomatis serovar L target. This should not be described as comprehensive Chlamydia genotyping or individual L1/L2/L3 typing; the doctor interprets the laboratory report with the clinical picture.

Genital and liquid cytology

  • Genital swab
  • LBC: ThinPrep® or SurePath™

Urine and semen

  • Urine collected to the selected test's instructions
  • Semen when accepted for the selected module

Extragenital swabs

  • Oropharyngeal swab (throat swab / ป้ายคอหอย)
  • Anorectal swab
14-target panelUrine or an appropriate site-specific swab, commonly genital or anorectal; exact laboratory acceptance is confirmed before collection.
Essential STI moduleGenital swab, urine, semen, LBC, oropharyngeal swab, or anorectal swab.
Genital Ulcer moduleGenital swab, urine, or LBC.
Candidiasis moduleGenital swab, urine, or LBC.
Bacterial Vaginosis moduleGenital swab or LBC.
Full 28-target optionGenital swab or LBC.
Exposure site matters: A urine or genital result does not reliably exclude infection confined to the throat or rectum. Tell the doctor which sites were exposed so the correct specimen can be considered.
Limits

What these PCR panels do not replace

  • HIV: requires a separate blood-based HIV test selected according to the window period.
  • Hepatitis B and C: require separate blood tests when indicated.
  • Syphilis: standard serology remains important. A local-specimen T. pallidum PCR target does not replace blood testing when syphilis is suspected or screened for.
  • Examination: ulcers, discharge, pelvic pain, testicular pain, proctitis, or recurrent symptoms may need physical examination and other tests.
  • Antimicrobial susceptibility: PCR detects genetic targets but generally does not show which antibiotic will work; culture may be needed in selected situations.
Results

How results are interpreted

  • A detected target must be matched to symptoms, examination, specimen site, and whether that organism can be colonising rather than causing disease.
  • A negative result covers only the organisms in the selected panel and the site sampled.
  • Testing too soon, an unsuitable specimen, recent treatment, or low organism quantity can affect interpretation.
  • Candida and BV-associated targets do not automatically mean an STI or that medicine is required.
  • Partner testing, treatment, repeat testing, culture, or additional blood tests may be advised depending on the result.

Laboratory reporting is generally around three days, but exact timing can vary. The clinic will explain how results will be communicated and whether a follow-up consultation is needed.

Frequently asked questions

Which STI PCR panel should I choose?

The best panel depends on symptoms, exposure site, organisms of concern, and whether blood-based tests are also needed. The doctor can match the panel and specimen to your situation rather than automatically ordering the largest panel.

Can a urine STI PCR test detect throat or rectal infection?

Not reliably. Infection can be limited to the throat or rectum, so an oropharyngeal or anorectal swab may be needed when those sites were exposed. Specimen eligibility also depends on the selected laboratory panel.

Does the 28-target panel include everything in the 14-target panel?

No. The panels overlap but are not nested. For example, the 14-target panel includes Group B Streptococcus, while the 28-target option uses different grouped targets and does not include Group B Streptococcus.

Does a positive Candida or bacterial-vaginosis target mean I have an STI?

Not necessarily. Candida and BV-associated organisms can be present without a classical sexually transmitted infection, and detection alone does not always mean treatment is needed. Symptoms, examination, organism pattern, and clinical context matter.

Are HIV, hepatitis and syphilis blood tests included in these PCR panels?

No. HIV and hepatitis testing use separate blood tests. Although some molecular panels contain a Treponema pallidum target, local specimen PCR does not replace standard syphilis blood testing when serology is clinically indicated.

How long do STI PCR panel results take?

Laboratory reporting is generally around three days, but timing can vary with the panel, specimen, transport, and laboratory workflow. The clinic will explain the expected timing for the selected test.

Not sure which panel or specimen you need?

Contact Klaibaan Clinic with your symptoms, approximate exposure timing, and exposure sites. The doctor can help select an appropriate panel and explain the current testing options.

Medical note: This guide provides general information. Test selection, specimen choice, diagnosis, and treatment require individual clinical assessment. Seek urgent hospital care for severe or rapidly worsening symptoms.